Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1991* | 2020 |
Molecular landmarks of tumor hypoxia across cancer types V Bhandari, C Hoey, LY Liu, E Lalonde, J Ray, J Livingstone, R Lesurf, ... Nature genetics 51 (2), 308-318, 2019 | 585 | 2019 |
Widespread and functional RNA circularization in localized prostate cancer S Chen, V Huang, X Xu, J Livingstone, F Soares, J Jeon, Y Zeng, JT Hua, ... Cell 176 (4), 831-843. e22, 2019 | 381 | 2019 |
The evolutionary landscape of localized prostate cancers drives clinical aggression SMG Espiritu, LY Liu, Y Rubanova, V Bhandari, EM Holgersen, LM Szyca, ... Cell 173 (4), 1003-1013. e15, 2018 | 248 | 2018 |
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ... European urology 72 (5), 665-674, 2017 | 184 | 2017 |
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open … J Guinney, T Wang, TD Laajala, KK Winner, JC Bare, EC Neto, SA Khan, ... The Lancet Oncology 18 (1), 132-142, 2017 | 168 | 2017 |
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ... EBioMedicine 31, 182-189, 2018 | 150 | 2018 |
Divergent mutational processes distinguish hypoxic and normoxic tumours V Bhandari, CH Li, RG Bristow, PC Boutros Nature communications 11 (1), 737, 2020 | 118 | 2020 |
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression S Cao, JR Wang, S Ji, P Yang, Y Dai, S Guo, MD Montierth, JP Shen, ... Nature biotechnology 40 (11), 1624-1633, 2022 | 51 | 2022 |
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples MH Bailey, WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, ... Nature communications 11 (1), 4748, 2020 | 44 | 2020 |
Quantifying the influence of mutation detection on tumour subclonal reconstruction LY Liu, V Bhandari, A Salcedo, SMG Espiritu, QD Morris, T Kislinger, ... Nature Communications 11 (1), 6247, 2020 | 23* | 2020 |
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial SB Coutts, S Ankolekar, R Appireddy, JF Arenillas, Z Assis, P Bailey, ... The Lancet 403 (10444), 2597-2605, 2024 | 21 | 2024 |
Comparing continuous and discrete analyses of breast cancer survival information V Bhandari, PC Boutros Genomics 108 (2), 78-83, 2016 | 11 | 2016 |
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... nature genetics 55 (6), 1076-1076, 2023 | 2 | 2023 |
Author Correction: The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 614 (7948), E42-E42, 2023 | 2 | 2023 |
Author Correction: Pan-cancer analysis of whole genomes Nature 614 (7948), E39-E39, 2023 | 2 | 2023 |
Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours V Bhandari, CH Li, RG Bristow, PC Boutros nature communications 13 (1), 7569, 2022 | 2 | 2022 |
Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer S Cao, JR Wang, S Ji, P Yang, MD Montierth, S Guo, JP Shen, X Zhao, ... bioRxiv, 2020.09. 30.306795, 2020 | 2 | 2020 |
Genomic evolution shapes prostate cancer disease type DJ Woodcock, A Sahli, R Teslo, V Bhandari, AJ Gruber, A Ziubroniewicz, ... Cell Genomics 4 (3), 2024 | 1 | 2024 |
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, A Weerasinghe, ... Nature Publishing Group UK, 2020 | 1 | 2020 |